Your browser doesn't support javascript.
loading
KCNQ1 variant rs163184 is a potential biomarker of glycemic response to exenatide.
Geng, Zhaoxu; Li, Qian; Huang, Rong; Wang, Jing; Weng, Jianping; Zhou, Kaixin; Liang, Hua; Wang, You.
Afiliación
  • Geng Z; Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
  • Li Q; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Huang R; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Wang J; Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Weng J; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Zhou K; Department of Endocrinology, The First Affiliated Hospital of USTC, Division of Life Sciences & Medicine, University of Science & Technology of China, Hefei, Anhui, China.
  • Liang H; College of Life Sciences, University of Chinese Academy of Sciences, Beijing, China.
  • Wang Y; Department of Endocrinology & Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
Pharmacogenomics ; 23(6): 355-361, 2022 04.
Article en En | MEDLINE | ID: mdl-35311356

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Canal de Potasio KCNQ1 Límite: Humans Idioma: En Revista: Pharmacogenomics Asunto de la revista: FARMACOLOGIA / GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Canal de Potasio KCNQ1 Límite: Humans Idioma: En Revista: Pharmacogenomics Asunto de la revista: FARMACOLOGIA / GENETICA MEDICA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido